Author

Lemieux J

The Broad Institute - Cited by 6,605 - malaria - molecular biology

Biography

Dr. Lemieux J  is currently working in Deschênes-Fabia Breast Disease Center, Saint-Sacrement Hospital, CHU de Quebec, 1050 chemin Sainte-Foy, Quebec, QC, Canada He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
Title
Cited by
Year
Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness
F Obermeyer, M Jankowiak, N Barkas, SF Schaffner, JD Pyle, ...Science 376 (6599), 1327-1332, 2022202
111
2022
Comparative transmissibility of SARS-CoV-2 variants delta and alpha in New England, USA
R Earnest, R Uddin, N Matluk, N Renzette, SE Turbett, KJ Siddle, C Loreth, ...Cell Reports Medicine 3 (4), 2022202
104
2022
Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants
NL Welch, M Zhu, C Hua, J Weller, ME Mirhashemi, TG Nguyen, ...Nature medicine 28 (5), 1083-1094, 2022202
85
2022
Duration of shedding of culturable virus in SARS-CoV-2 Omicron (BA. 1) infection
J Boucau, C Marino, J Regan, R Uddin, MC Choudhary, JP Flynn, G Chen, ...New England Journal of Medicine 387 (3), 275-277, 2022202
84
2022
Defining the risk of SARS-CoV-2 variants on immune protection
MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ...Nature 605 (7911), 640-652, 2022202
83
2022
Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for coronavirus disease 2019 (COVID-19)
J Boucau, R Uddin, C Marino, J Regan, JP Flynn, MC Choudhary, G Chen, ...Clinical Infectious Diseases 76 (3), e526-e529, 2023202
47
2023
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
MJ Siedner, J Boucau, RF Gilbert, R Uddin, J Luu, S Haneuse, T Vyas, ...JCI insight 7 (2), 2022202
41
2022
Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak
KJ Siddle, LA Krasilnikova, GK Moreno, SF Schaffner, J Vostok, ...Cell 185 (3), 485-492. e10, 2022202
37
2022
Detection of the omicron variant virus with the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
J Regan, JP Flynn, MC Choudhary, R Uddin, J Lemieux, J Boucau, ...Open Forum Infectious Diseases 9 (3), ofac022, 2022202
31
2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection
J Boucau, C Marino, J Regan, R Uddin, MC Choudhary, JP Flynn, G Chen, ...medRxiv, 2022202
21
2022
Enhanced virus detection and metagenomic sequencing in patients with meningitis and encephalitis
A Piantadosi, SS Mukerji, S Ye, MJ Leone, LM Freimark, D Park, G Adams, ...MBio 12 (4), 10.1128/mbio. 01143-21, 212
20
2021
Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients
E Normandin, KB Holroyd, SI Collens, BM Shaw, KJ Siddle, G Adams, ...Journal of the Neurological Sciences 430, 120023, 2021202
18
2021
Detection of Borrelia burgdorferi Cell-free DNA in Human Plasma Samples for Improved Diagnosis of Early Lyme Borreliosis
JA Branda, JE Lemieux, L Blair, AA Ahmed, DK Hong, S Bercovici, ...Clinical Infectious Diseases 73 (7), e2355-e2361, 2021202
18
2021
Determining the incidence of asymptomatic SARS-CoV-2 among early recipients of COVID-19 vaccines (DISCOVER-COVID-19): a prospective cohort study of healthcare workers before …
CM North, A Barczak, RH Goldstein, BC Healy, DM Finkelstein, DD Ding, ...Clinical Infectious Diseases 74 (7), 1275-1278, 2022202
17
2022
Vaccine breakthrough infection with the SARS-CoV-2 Delta or Omicron (BA. 1) Variant leads to distinct profiles of neutralizing antibody responses
MS Seaman, MJ Siedner, J Boucau, CL Lavine, F Ghantous, MY Liew, ...medRxiv, 2022202
16
2022
Virologic characterization of symptom rebound following nirmatrelvir-ritonavir treatment for COVID-19
J Boucau, R Uddin, C Marino, J Regan, JP Flynn, MC Choudhary, G Chen, ...medRxiv, 2022.05. 24.22275326, 2022202
13
2022
SARS-CoV-2 reinfection in a liver transplant recipient
CH Tomkins-Tinch, JS Daly, A Gladden-Young, NM Theodoropoulos, ...Annals of Internal Medicine 174 (8), 78-80, 2021202
11
2021
Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts
KJ Siddle, LA Krasilnikova, GK Moreno, SF Schaffner, J Vostok, ...Medrxiv, 2021.. 20.21265137, 2021202
10
2021
Vaccine serologic responses among transplant patients associate with COVID-19 infection and T peripheral helper cells
Vaccine serologic responses among transplant patients associate with COVID-1 infection and T peripheral helper cellsJE Lemieux, A Li, M Gentili, CA Perugino, ZF Weiss, K Bowman, ...MedRxiv, 2021.07. 11.21260338, 2021202
9
2021
Coronavirus Disease 2019 (COVID-19) diagnostic clinical decision support: a pre-post implementation study of CORAL (COvid Risk cALculator)
Coronavirus Disease 201 (COVID-1) diagnostic clinical decision support: a pre-post implementation study of CORAL (COvid Risk cALculator)CM Dugdale, DM Rubins, H Lee, SM McCluskey, ET Ryan, CN Kotton, ...Clinical Infectious Diseases 73 (12), 2248-2256, 2021202
9
2021

Referred From: https://scholar.google.com/citations?hl=en&user=fUbbBPQAAAAJ

Cited by
Citations 6605
h-index 29
i10-index 41
Recommended Journals
Open Access Journals